Use Options For a Chance To Buy CLVS at a 45% Discount

Looking back to 117 days ago, Clovis Oncology Inc (CLVS) priced a 3,525,641 share secondary stock offering at $78.00 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time and based on early trading on Monday, the stock is now 27.5% higher than the offering price..
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.